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Abstract
Background: Ear infection is one of the most widespread illness usually 
caused by bacteria or viruses, and which can be extremely painful. 
They are the most common reason for parents to bring their children 
to clinicians. The aim of this study is to determine the prevalence and 
antibiotic susceptibility pattern of common bacterial ear pathogens 
isolated from patients in Tripoli, North Lebanon during the period of 
7 years.
Methods: A total of 481 bacterial ear pathogens were isolated from 
deep ear swab specimens of patients who came to Nini hospital 
clinical laboratory in Tripoli, North Lebanon. Culture, identification and 
antibiotic susceptibility of suspected isolates were carried out through 
conventional tests. API identification and serotyping were performed 
according to standard protocols proposed by the Référentiel en 
Microbiologie Médicale and the recommendations of the European 
Committee on Antimicrobial Susceptibility Testing.
Results: Out of 481, non-Enterobacteriaceae Gram negative rods 
were predominant (36.4%) followed by Staphylococcus aureus 
(24.8%), Enterobacteriace ae (16.8%), Haemophilus influenzae (10%), 
β-hemolytic streptococci (6.2%), Streptococcus pneumoniae (5.4%) 
and Moraxella catarrhalis (0.4%). Susceptibility testing showed the 
prevalence rate of methicillin-resistant S. aureus was 18.5% and of 
penicillin-non-susceptible pneumococci was 30.8%. Enterobacteriaceae 
and H. influenzae had susceptibilities of 18.5% and 80% to ampicillin, 
respectively. P. aeruginosa susceptibility to piperacillin–tazobactam and 
imipenem were very low, with 9.4% and 6.6%, respectively. Overall, 
H. influenzae and S. pyogenes isolates were also among the more 
susceptible isolates to antibiotics.
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Introduction
Ear infection is one of the most common illness 
which can be extremely painful because of inflam-
mation and fluid buildup in the ear [1,2]. Its illness 
can affect the ear canal, the eardrum, or the middle 
ear. Ear infections are mostly observed in babies and 
young children, although it can occur in people of 
any age. Most children will have had at least one 
acute ear infection episode before three years of 
age. The main symptoms are ear pain, feeling un-
well, fullness in the ear, hearing loss, ringing in the 
ear, discharge from the ear, nausea, vomiting and 
vertigo. Symptoms may follow a respiratory infection 
such as the common cold [1,2]. In addition, acute 
otitis externa (AOE), also known as ‘swimmer’s ear’, 
is an inflammation or infection of external auditory 
canal, the auricle, or both which found often in 
adults[3]. However, otitis media with effusion (OME) 
is defined as a buildup of fluid in the middle ear 
but without symptoms and signs of infection, but 
this fluid can become occasionally infected, leading 
to acute otitis media (AOM). Numerous etiology of 
OME were described including allergies, irritants, 
previous respiratory infections, drinking while lay-
ing on your back and changes in air pressure [2,3].
Both features of AOE and AOM can be pain-
ful. They are often caused by bacteria, but can 
also be caused by viruses. Although the etiologi-
cal diagnosis is rarely discovered, bacterial infec-
tions are the most common cause of AOE and 
AOM [3]. Analgesics and fever-reducing drugs are 
the main treatment but also antibiotics are pre-
scribed by clinicians for the cure of ear infections. 
The clinicians’ decision will consider several factors 
for an ear infection such as age, illness severity, 
certainty a bacterial infection is present, and op-
tions for follow-up [4]. According to these factors, 
the decision will be either treat with antibiotics 
or waited a few days before prescribing antibiot-
ics . Ear infections usually clear up on their own 
within a few days, and serious complications are 
rare. It has been noted that when an ear infection 
is caused by a virus, antibiotics will not help to get 
better and may even cause harm in both children 
and adults [4]. Nevertheless, ear infections are a 
leading cause for antibiotic prescriptions. 
In Lebanon, numerous recent studies reported 
an increasing high rates of resistant bacteria iso-
lates from clinical and commensal sources to most 
antimicrobials [5-21]. However, few data about the 
bacterial ear pathogens in Lebanon is available. For 
this reason, this investigation aimed to determine 
the occurrence of pathogens causing ear infections 
and its antibiotic susceptibility patterns in Tripoli, 
North Lebanon during the period of 7 years.
Conclusion: This study revealed widely different antibiotic resistance 
rates of bacterial ear pathogens among the examined patients in 
Tripoli, North Lebanon. These findings provide useful information to 
physicians to select the proper antibiotic for treatment of ear infections 
in North Lebanon. Also, allow health authorities to develop effective 
program to combat antibiotic resistance in Lebanon.
Keywords: Bacterial ear pathogens, Antibiotic susceptibility, 
Pseudomonas aeruginosa, Staphylococcus aureus, Haemophilus 
influenzae, Lebanon
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Material and methods
This study was conducted at clinical microbiology 
laboratory of Nini hospital in Tripoli, North Lebanon 
over the period from January 2009 to December 
2015. Deep ear swab specimens were obtained by 
clinicians from both ears of 463 patients (235 males 
and 228 females, ranging in age from 1 month to 
85 years, with a mean age of 20 years) with pre-
senting ear illness symptoms. All collected samples 
were transported immediately using Amies agar gel 
(Oxoid®, United Kingdom) to the microbiology labo-
ratory.
Culture of specimens was performed according 
to standard protocols proposed by the Référentiel 
en Microbiologie Médicale (REMIC) using four differ-
ent media including Columbia blood agar, Columbia 
CNA blood agar with 5% sheep blood, Drigalski 
and Chocolate agar with bacitracin [22]. The iden-
tification of Enterobacteriaceae, non-Enterobacte-
riaceae Gram negative rods and Haemophilus spp. 
was carried out through the use of API-20E, API-
20NE and API-NH (bioMérieux® - France), respec-
tively. The identification of β-hemolytic streptococci 
belonging to Lancefield groups A, C, and G was 
performed by agglutination techniques (Bio-Rad®, 
France). The detection of α-hemolytic S. pneumoni-
ae was carried out using the test of optochin sus-
ceptibility and latex agglutination tests (Bio-Rad®, 
France). The identification of S. aureus was realized 
using catalase test and Pastorex™ Staph Plus kit 
(Bio-Rad®, France).
The antibiotic susceptibility testing was performed 
by disk diffusion method on Mueller Hinton agar for 
S. aureus, Enterobacteriaceae and non-Enterobac-
teriaceae Gram negative rods (Bio-Rad®, France), 
and on Mueller Hinton agar supplemented with 5% 
blood and 20 mg/l β-NAD (MHF) for H. influenza, 
M. catarrhalis , S. pneumoniae and β-hemolytic 
streptococci according to the recommendations of 
the European Committee on Antimicrobial Suscep-
tibility Testing (EUCAST). 
 Statistical analyses were performed with Graph-
Pad Prism 6.0 (GraphPad Software Inc., San Diego, 
CA) using the Fisher’s exact test to explore the as-
sociation between bacterial infections and age of 
patients (≤10 years and >11 years). The general sig-
nificance level was set at a P-value below 0.05. 
Results
A total of 481 non-duplicated isolates were re-
covered from patient’s specimens. Table 1 shows 
the distribution of isolates based on age of patients. 
Out of 481, non-Enterobacteriaceae Gram negative 
rods were the most frequently isolates (175/481; 
36.4%) followed, by S. aureus (119/481; 24.8%), 
Enterobacteriaceae (81/481; 16.8%), H. influenzae 
(48/481; 10%), β-hemolytic streptococci (30/481; 
6.2%), S. pneumoniae (26/481; 5.4%) and M. ca-
tarrhalis (2/481; 0.4%).
Furthermore, approximately half of infected pa-
tients were children aged ≤ 10 years old (236/481; 
49%). H. influenzae (47/48; 98%), S. pneumoniae 
(25/26; 96%) and S. pyogenes (20/24; 83%) were 
almost present in ear infection of this children group 
(Table 1).
The majority of cases occurred mostly during the 
winter season (158/481; 32.8%) followed by spring 
season (126/481; 26.2%) and fall season (110/481; 
22.9%). However, the lowest number of cases was 
found in summer season (87/481; 18.1%)
The results of antimicrobial susceptibility tests of all 
tested isolates are presented in Tables 2-4.
Discussion
According to our laboratory records, the majority 
of ear infection cases were due to P. aeruginosa, 
S. aureus, H. influenzae and S. pneumoniae with an 
average number of 19.4, 17, 6.9 and 3.7 cases per 
year over the last 7 years, respectively. H. influenzae, 
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S. pneumoniae and S. pyogenes infections were sig-
nificantly predominant (p-value<0.001) in children 
aged less than 10 years. These three bacteria remain 
a leading cause of serious illness among babies and 
young children worldwide and are a frequent cause 
of ear infections [23]. However, P. aeruginosa was 
significantly prevalent in patients aged more than 
10 years (p-value<0.001). P. aeruginosa ear infec-
tions are more prevalent in older population and 
often more difficult to treat [24]. No significant dif-
ference was found concerning the distribution of 
other reported bacteria species.
Otherwise, although ear infections occurred all 
year round, they were more common during the 
winter season when people spend more time in 
close contact indoors, children attending daycare 
and climate become colder.
This study confirms the wide range rates of an-
tibiotic resistance among the majority of bacterial 
ear pathogens isolates in Tripoli, North Lebanon. 
Regarding P. aeruginosa, several Lebanese investi-
gation showed the emergence of multidrug resis-
tance strains. Al Bayssari et al. [25] reported the 
emergence of P. aeruginosa producing IMP-15 and 
VIM-2 carbapenemases and the disruption of the 
oprD gene. Moreover, Chamoun et al. [5] showed a 
trend of increasing resistance of antibiotics in Leba-
non between 2011 and 2013, with the highest re-
sistance being found to imipenem (27.2%) followed 
by aztreonam (23.7%) and ciprofloxacin (22.7%). 
Another report showed mean resistant rates of 
8.7% to imipenem, 13% to aztreonam and 8.7% 
to ciprofloxacin [19]. In our study, P. aeruginosa re-
sistance to aztreonam and ciprofloxacin was 16.3% 
and 10.3%, respectively, and within range of the re-
spective rates reported previously. A slight decrease 
Received 2-4-2017; Accepted 13-4-2017
Table 1. Distribution of bacterial ear pathogens strains according to age of patients.
 Number of strains
Age of patients [0;10] [11;20] [21;30] [31;40] [41;50] [51;60] [61;90] Total
P. aeruginosa 49 29 10 9 12 17 10 136
Pseudomonas spp. 6 8 3 1 1 1 0 20
Alcaligenes spp. 4 2 5 1 1 1 0 14
Acinetobacter baumannii 1 0 2 1 0 1 0 5
E. coli 8 6 1 0 3 2 4 24
Proteus spp. 7 6 1 2 0 2 1 19
Enterobacter spp. 4 8 2 0 0 0 0 14
Klebsiella pneumoniae 0 3 1 1 2 2 2 11
Citrobacter spp. 0 4 0 0 0 1 0 5
Morganella morganii 3 1 0 0 0 0 1 5
Providencia spp. 1 2 0 0 0 0 0 3
H. influenzae 47 1 0 0 0 0 0 48
M. catarrhalis 2 0 0 0 0 0 0 2
S. aureus 54 16 11 9 10 10 9 119
S. pneumoniae 25 0 0 0 0 1 0 26
S. pyogenes 20 2 1 1 0 0 0 24
Group C & group G streptococci 5 0 0 0 0 1 0 6
Total 236 88 37 25 29 39 27 481
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Figure 1. The seasonal distribution of ear infection cases in Lebanese patients.
in carbapenem resistance (6.6%) was observed in 
the present study, while susceptibility to ticarcillin 
and ticarcillin-clavulanate was maintained at around 
80% and to piperacillin and piperacillin–tazobactam 
at around 85%.
Concerning H. influenzae, antibiotic resistance is 
more diverse and widespread than is commonly ex-
pected. H. influenzae isolates in our study revealed 
no-resistance to amoxicillin–clavulanate, cephalo-
sporins, gentamicin, rifampicin and chlorampheni-
col. However, we note an emergence of resistance 
to kanamycin (2%), fluoroquinolones (3.4%), and 
tetracycline (4.2%). Higher resistant rate of H. in-
fluenzae was found against ampicillin (20%). No 
BLNAR isolates were found which suggest that 
all ampicillin-resistant bacteria were producer of 
β-lactamase. Two recent studies conducted in Trip-
oli, North Lebanon described that all β-lactamase 
producing H. influenzae were TEM-1, which is the 
most frequent resistance mechanism reported for 
this species [18,26].
Among the Enterobacteriaceae, E. coli was the 
predominant species. Various previous studies con-
ducted in Lebanon showed a high prevalence of ex-
tended-spectrum beta-lactamases (ESBL)-producing 
E. coli with a mean rate of 20% [7,15] to 32% [5]. In 
addition, several reports described the emergence 
of carbapenemase-producing E. coli isolates, partic-
ularly OXA-48 [class D β-lactamases] [13,15,27-29]. 
In the present study, ESBL-producing E. coli was in 
the range of the previous reports since ertapenem, 
imipenem and meropenem resistance rates were 
about 6%, 0% and 0%, respectively. Ciprofloxacin 
resistance was about 30%, which is lower than that 
lately reported in the nationwide study [5], but in 
the range of that recently reported in Tripoli, North 
Lebanon [7,15,21].
S. aureus is a major pathogen for both hospital and 
community-acquired infections. Of the 119 isolated 
strains in our study, 21 (18%) MRSA. The high rate of 
MRSA observed in our study may result that S. aureus 
ear infections is becoming more difficult to treat. A 
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Table 2. Percentage of antibiotic susceptibility of major Enterobacteriaceae isolates.
 E. coli
 
N=24
(%)
Proteus spp.
N=19
(%)
Enterobacter spp.
N=14
(%)
Klebsiella pneumoniae
N=11
(%)
Enterobacteriaceae*
 
Total N=81
(%)
AMP 20.8 47.4 0 0 18.5
AMC 70.8 89.5 0 81.8 59.3
TIC 37.5 57.9 92.9 0 50.6
TCC 79.2 94.7 92.9 81.8 88.9
PIP 37.5 57.9 92.9 0 50.6
PPT 94.1 100 92.9 81.8 96.6
CFX 58.3 57.9 0 81.8 46.9
CXM 70.8 89.5 71.4 81.8 75.3
FOX 83.3 100 0 90.9 76.5
CFM 79.2 89.5 92.9 81.8 86.4
CTX 79.2 89.5 92.9 81.8 87.7
CAZ 79.2 89.5 92.9 81.8 87.7
FEP 79.2 89.5 100 81.8 88.9
ATM 79.2 89.5 92.9 81.8 87.7
ERT 94.1 100 100 87.5 94.8
IMP 100 78.9 85.7 90.9 88.9
MEM 100 100 91.7 87.5 94.8
GMN 66.7 78.9 100 81.8 81.5
TMN 60.9 84.2 85.7 81.8 76.2
NET 75 78.9 92.9 81.8 84.0
AKN 95.8 100 100 100 98.8
OFX 66.7 73.7 85.7 72.7 72.8
CIP 70.8 78.6 92.9 72.7 76.5
TET 58.3 0 57.1 70 46.2
MNO 66.7 0 57.1 80 51.2
TGC 95.8 0 85.7 90.9 77.8
CS 100 0 100 100 65.4
FSF 100 89.5 78.6 63.6 85.2
SXT 58.3 57.9 92.9 72.7 69.1
 
AMP, ampicillin (10 μg) ; AMC, amoxicillin/clavulanate (20/10 μg) ; TIC, ticarcillin (75 μg) ; TCC, ticarcillin/clavulanate (75/10 μg) ; PIP, 
piperacillin (30 μg) ; PPT, piperacillin/tazobactam (30/6 μg) ; ATM, aztreonam (30 μg) ; IMP, imipenem (10 μg) ; MEM, meropenem (10 
μg) ; ERT, ertapenem (10 μg) ; CFX, cefalexin (30 μg) ; CXM, cefuroxime (30 μg) ; FOX, cefoxitin (30 μg) ; CFM, cefixim (5 μg) ; CTX, ce-
fotaxime (5 μg) ; FEP, cefepime (30 μg) ; CAZ, ceftazidime (30 μg) ; GMN, gentamicin (10 μg) ; TMN, tobramycin (10 μg) ; AKN, amikacin 
(30 μg) ; NET, netilmicin (10 μg) ; OFX, ofloxacin (5 μg) ; CIP, ciprofloxacin (5 μg) ; TET, tetracycline (30 μg); MNO, minocycline (30 μg) ; 
TGC, tigecycline (15 μg) ; CS, colistin (50 μg) ; FSF, fosfomycin (200 μg) ; SXT, trimethoprim/sulfamethoxazole (1,25/23,75 μg). 
*Enterobacteriaceae isolates include 24 E. coli, 19 Proteus spp., 14 Enterobacter spp., 11 K. pneumoniae, 5 Citrobacter spp., 5 Morganella 
morganii and 3 Providencia spp.
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recent nationwide study revealed an increase in the 
prevalence of MRSA in Lebanese hospitals [5]. This 
prevalence was two times higher than that reported in 
healthy schoolchildren in the same region [30]. In ad-
dition, the study found that S. aureus isolates are still 
susceptible to vancomycin, teicoplanin and linezolid.
With regard to Streptococcus group, S. pneu-
moniae was the predominant species followed by 
S. pyogenes. Of the 26 S. pneumoniae isolates, 
30.8% were penicillin non-susceptible S. pneu-
moniae (PNSP),and 34.6% were resistant to both 
erythromycin and cotrimoxazole. A national pro-
spective study reported that resistance rates to peni-
cillin, erythromycin and cotrimoxazole were 17.4%, 
29.3% and 54%, respectively [31]. However, higher 
level of resistance to penicillin (53.8%), erythromycin 
(41.3%) and cotrimoxazole (56.7%) was reported in 
another nationwide retrospective survey [5]. How-
ever, all S. pneumoniae isolates were susceptible 
to vancomycin, teicoplanin, linezolid, pristinamycin, 
tigecycline, gentamicin, streptomycin and fluoroqui-
nolones. Penicillin, erythromycin and cotrimoxazole 
high resistance in S. pneumoniae has been incrimi-
nated due to antibiotic misuse and overuse of these 
antibiotics in Lebanon, since all oral antibiotics are 
easily available over the counter. While S. pyogenes 
remained sensitive to the majority of antibiotics dur-
ing the study period.
Table 3. Percentage of antibiotic susceptibility of major non-Enterobacteriaceae Gram negative rods 
isolates.
 P. aeruginosa
N=136
(%)
Pseudomonas spp.
N=20
(%)
Alcaligenes spp.
N=14
(%)
Acinetobacter baumannii
N=5
(%)
TIC 79.4 88.9 100 100
TCC 80.9 90 100 80
PIP 85.3 95 100 100
PPT 90.6 100 100 100
CAZ 91.9 85 85.7 20
FEP 89 60 64.3 100
ATM 83.7 50 21.4 0
IMP 93.4 85 92.9 100
MEM 97.6 100 100 100
GMN 79.4 65 35.7 80
TMN 88.2 60 35.7 80
NET 79.1 60 42.9 100
AKN 89.7 70 42.9 100
OFX 64.7 60 35.7 80
CIP 89.7 65 57.1 80
CS 100 90 85.7 100
FSF 68.4 45 21.4 0
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Table 4. Percentage of antibiotic susceptibility of S. aureus, S. pneumoniae, S. pyogenes and  
H. influenzae.
 
S. aureus
N=119
(%)
S. pneumoniae
N=26
(%)
S. pyogenes
N=24
(%)
H. influenzae
N=48
(%)
P - - 100 80
AMP - - - 80
AMC - - - 100
OX - 69.2 - -
FOX 81.5 - - -
CFX - - - 100
CXM - - - 100
CTX - - - 100
VAN 100 100 100 -
TEI 100 100 100 -
S - 100 100 -
KMN 78.2 - - -
TMN 89.1 - - -
GMN 90.8 100 100 -
C 93.3 100 100 100
TET 94.1 76.9 87.5 95.8
MNO 100 - - -
TGC 100 100 100 -
E 85.7 65.4 95.8 -
CD 95.8 69.2 95.8 -
PTN 100 100 100 -
LZD 100 100 100 -
FUS 79.8 - - -
NA - - - 93.1
OFX - - - 96.6
CIP - - - 96.6
LVX 87.7 100 100 -
MOX 87.7 100 100 -
RIF 98.3 96.2 95.8 100
SXT 95 65.4 45.8 64.6
FSF 95.8 - - -
NOV 82.8 - - -
P, penicillin G (1 UI) ; AMP, ampicillin (2 μg) ; AMC, amoxicillin/clavulanate (2/1 μg) ; CFX, cefalexin (30 μg) ; CXM, cefuroxime (30 μg) ; 
CTX, cefotaxime (5 μg); OX, oxacillin (1 μg) ; FOX, cefoxitin (30 μg); S, streptomycin (300 μg); KMN, kanamycin (30 μg); TMN, tobramycin 
(10 μg), GMN, gentamicin (10 μg for S. aureus and 500 μg for Streptococcus spp.), C, Chloramphenicol (30 μg); TET, tetracycline (30 μg) 
; MNO, minocycline (30 μg); TGC, tigecycline (15 μg); E, erythromycin (15 μg); CD, clindamycin (2 μg); PTN, pristinamycin (15 μg); LZD, 
linezolid (10 μg); TEI, teicoplanin (30 μg); VAN, vancomycin (5 μg); FUS, fusidic acid (10 μg); NA, nalidixic acid (30 μg); OFX, ofloxacin (5 μg) 
; CIP, ciprofloxacin (5 μg) ; LVX, levofloxacin (5 μg); MOX, moxifloxacin (5 μg); RIF, Rifampicin (5 μg) ; SXT, trimethoprim/sulfamethoxazole 
(1,25/23,75 μg); FSF, fosfomycin (200 μg); NOV, novobiocin (5 μg).
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In conclusion, this study indicates that the an-
tibiotic resistance rates of pathogens causing ear 
infection are widely varied among bacterial isolates 
in Tripoli, North Lebanon. These findings are prob-
ably correlated with the high spread of counterfeit 
medicines and the misuse and overuse of antibiot-
ics. Therefore, cultures and antibiotic susceptibility 
testing of bacterial ear pathogens are very impor-
tant to determine bacterial causes and to guide ap-
propriate treatment.
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